Chinas CanSino confident its mRNA COVID vaccine as good as ... - Nasdaq
| CJH Stock | EUR 3.64 0.02 0.55% |
Roughly 54% of CanSino Biologics' investor base is interested to short. The analysis of current outlook of investing in CanSino Biologics suggests that many traders are impartial regarding CanSino Biologics' prospects. The current market sentiment, together with CanSino Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use CanSino Biologics stock news signals to limit their universe of possible portfolio assets.
CanSino Biologics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CanSino daily returns and investor perception about the current price of CanSino Biologics as well as its diversification or hedging effects on your existing portfolios.
CanSino |
Chinas CanSino confident its mRNA COVID vaccine as good as ... Nasdaq
Read at news.google.com
 |
CanSino Biologics Fundamental Analysis
We analyze CanSino Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CanSino Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CanSino Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
CanSino Biologics is rated below average in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
CanSino Biologics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CanSino Biologics stock to make a market-neutral strategy. Peer analysis of CanSino Biologics could also be used in its relative valuation, which is a method of valuing CanSino Biologics by comparing valuation metrics with similar companies.
Peers
CanSino Biologics Related Equities
| LDZU | ASPEN PHARUNADR | 4.68 | ||||
| TSUA | Tsumura | 0.00 | ||||
| CJH | CanSino Biologics | 0.55 | ||||
| TKDA | Takeda Pharmaceutical | 0.81 | ||||
| GU5 | Guangzhou Baiyunshan | 0.93 | ||||
| MRK | Merck | 1.16 | ||||
| HPX | Hisamitsu Pharmaceutical | 1.59 | ||||
| 5EA | Elanco Animal | 1.60 | ||||
| 3KY | HANSOH PHARMAC | 2.70 |
Complementary Tools for CanSino Stock analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |